ʻO Covid-19 keiki a me ka pēpē: nā hōʻailona, ​​​​hōʻike a me nā kano

ʻO Covid-19: he aha ka "ʻaiʻē palekana", kahi e pilikia ai nā keiki?

Ke ao aku nei ka Pediatricians e pili ana i ka hopena o ka maʻi maʻi COVID-19 i ke olakino o nā keiki. ʻO kahi hanana i kapa ʻia ʻo "immune aie", i ka emi ʻana o nā hihia o ka nui o nā maʻi viral a me nā maʻi bacteria e hoʻoulu ai i ka nele o ka hoʻoulu ʻana.

ʻO ka maʻi maʻi COVID-19 a me nā ʻano like ʻole ka hoʻomaʻemaʻe a me ke kaʻawale kino i hoʻokō ʻia i loko o kekahi mau mahina e hiki ai ke hōʻemi i ka nui o nā hihia o nā maʻi infectious viral kaulana i hoʻohālikelike ʻia i nā makahiki i hala: influenza, chickenpox, misle… Akā, he mea maikaʻi anei kēia? ʻAʻole pono, e like me kahi noiʻi i paʻi ʻia e nā pediatrician Farani ma ka puke ʻepekema ʻepekema "Science Direct". Ua ʻōlelo ka hope i ka nele i ka hooikaika kino ma muli o ka emi ʻana o ka neʻe ʻana o nā microbial agents i loko o ka heluna kanaka a me ka nui o ka lohi ʻana i nā papahana o ka lāʻau lapaʻau ua alakaʻi i kahi "ʻaiʻē palekana", me ka piʻi nui ʻana o ka poʻe maʻalahi, ʻoi aku nā keiki.

Eia nō naʻe, hiki i kēia kūlana "hiki ke alakaʻi i nā maʻi maʻi nui i ka wā i kau ʻia ai nā hana lāʻau lapaʻau ʻole e ka maʻi maʻi SARS-CoV-2 ʻaʻole pono hou. “, Makau i na kauka. Ua maikaʻi kēia hopena ʻaoʻao i ka wā pōkole, no ka mea ua hiki ke pale i ka hoʻonui ʻana i nā lawelawe o ka haukapila i waena o kahi pilikia olakino. Akā ʻo ka nele hoʻoikaika kino ma muli o ka emi ʻana o ke kahe ʻana o nā microbes a me nā maʻi maʻi, a me ka hāʻule ʻana o ka uhi ʻana i ka lāʻau lapaʻau, ua alakaʻi i kahi "ʻaiʻē palekana" hiki ke loaʻa i nā hopena maikaʻi ʻole ke lawe ʻia ka maʻi maʻi. "ʻO ka lōʻihi o kēia mau manawa o ka 'haʻahaʻa viral a i ʻole bacterial exposure', ʻoi aku ka nui ka mea e hiki mai ana i na mai ahulau he lōʻihi. ", E ao aku i nā mea kākau o ka haʻawina.

ʻO ka liʻiliʻi o nā maʻi maʻi pediatric, nā hopena no nā keiki?

ʻO ka ʻoiaʻiʻo, ʻoi aku ka ikaika o kekahi mau maʻi maʻi i nā makahiki e hiki mai ana. Makaʻu ka poʻe Pediatrics ʻo ia paha ka hihia nā maʻi infectious pediatric kaiaulu, me ka nui o nā kipa ʻana i nā ulia pōpilikia a me nā hana i hōʻemi nui ʻia i ka wā paʻa, akā ma waho aʻe o ka wehe hou ʻana o nā kula. Ma waena o kēia mau mea: gastroenteritis, bronchiolitis (ma muli o ka respiratory syncytial virus), ʻaʻai moa, ʻotitis media acute, nā maʻi ʻeha o ka ʻōpū o luna a me lalo, a me nā maʻi bacterial invasive. Hoʻomanaʻo ka hui "ʻo kā lākou mea hoʻoulu he maʻi kamaliʻi, ʻoi loa ka viral, aneane hiki ʻole ke pale makahiki mua o ke ola. "

Eia nō naʻe, no kekahi o kēia mau maʻi, hiki i nā hopena maikaʻi ʻole uku ʻia e nā lāʻau lapaʻau. ʻO ia ke kumu e kāhea aku ai nā pediatricians i ka hoʻonui ʻana i ka mālama ʻana i nā papahana o ka lāʻau lapaʻau i kau ʻia, a no ka hoʻonui ʻana i ka heluna kanaka. E hoʻomaopopo ʻo Iulai i hala aku nei, ua makaʻala ka World Health Organization (WHO) a me Unicef ​​​​i kahi hāʻule "hoʻoweliweli" i ka helu o nā keiki. ka loaʻa ʻana o nā lāʻau lapaʻau ola i ka honua. ʻO kahi kūlana ma muli o ka hoʻopau ʻana i ka hoʻohana ʻana i nā lawelawe kano ma muli o ka maʻi maʻi maʻi COVID-19: 23 miliona mau keiki ʻaʻole i loaʻa i ʻekolu mau kano o ke kano kūʻē i ka diphtheria, tetanus a me pertussis i 2020, ʻo ia ka mea hiki kumu hou mai i nā makahiki e hiki mai ana.

Eia nō naʻe, ʻaʻole kekahi o nā maʻi maʻi maʻi i ke kumuhana o kahi papahana kano. Me he moa moa : ʻaelike nā kānaka a pau i ko lākou ola ʻana, ʻo ka pinepine i ka wā kamaliʻi, no laila ua manaʻo wale ʻia ka lāʻau lapaʻau no ka poʻe i pilikia i nā maʻi koʻikoʻi. I ka makahiki 2020, ua hōʻike ʻia he 230 mau hihia, he emi o 000%. Pono ʻo ka hiki ʻole o ka moa, "ʻO nā keiki liʻiliʻi i ʻaelike ʻia ma 2020 hiki ke hāʻawi i kahi kiʻekiʻe kiʻekiʻe i nā makahiki e hiki mai ana," wahi a nā mea noiʻi. Eia kekahi, e loaʻa i kēia mau keiki nā "ʻelemakule" hiki ke alakaʻi i ka nui o nā hihia koʻikoʻi. Ke alo nei me kēia pōʻaiapili pilikia o ke ahulau hou, makemake ka hope e hoʻonui i nā ʻōlelo aʻoaʻo kano no ka moa, no laila, he rotavirus a me maningococci B a me ACYW.

ʻO Covid-19 pēpē a me ke keiki: nā hōʻailona, ​​​​nā hoʻokolohua, nā kano

He aha nā hōʻailona o Covid-19 i nā ʻōpio, nā keiki a me nā pēpē? He lele loa anei na keiki? Hoʻouna lākou i ka coronavirus i nā pākeke? PCR, kohu: he aha ka hoʻāʻo e ʻike ai i ka maʻi Sars-CoV-2 i ka muli loa? Lawe mākou i ka ʻike i kēia lā ma Covid-19 i nā ʻōpio, nā keiki a me nā pēpē.

Covid-19: ʻOi aku ka lele ʻana o nā keiki liʻiliʻi ma mua o nā ʻōpio

Hiki i nā keiki ke hopu i ka SARS-CoV-2 coronavirus a hāʻawi iā ia i nā keiki ʻē aʻe a me nā pākeke, ʻoi aku hoʻi i ka hale hoʻokahi. Akā ua makemake ka poʻe noiʻi e ʻike inā ʻoi aku ka nui o kēia pilikia e like me ka makahiki, a ua ʻike ʻia ʻo nā keiki ma lalo o 3 mau makahiki ka mea nui e hoʻopili i ka poʻe a puni lākou.

ʻOiai ua hōʻike nā haʻawina i nā keiki maʻamau nā ʻano koʻikoʻi liʻiliʻi o COVID-19 ma mua o ka poʻe mākua, ʻaʻole ia e hōʻike i ka liʻiliʻi o ka lawe ʻana i ka coronavirus. No laila ke mau nei ka nīnau o ka ʻike inā he like a emi ʻole paha lākou ma mua o ka poʻe mākua, ʻoiai ʻoi aku ka paʻakikī o ka ʻikepili i loaʻa e loiloi pololei i kā lākou kuleana. i ka dynamics o ke ahulau. I loko o kahi noiʻi hou i paʻi ʻia ma ka puke pai "JAMA Pediatrics", makemake nā mea noiʻi Kanada e ʻike inā aia kahi ʻokoʻa o ka hiki ke hoʻoili ʻia o SARS-CoV-2 ma ka home. e na keiki liilii hoʻohālikelike ʻia me nā keiki ʻōpio.

Wahi a nā hopena noiʻi i haʻi ʻia e ka New York Times, ʻoi aku ka nui o nā pēpē a me nā kamaliʻi e hoolaha aku i ka COVID-19 i nā poʻe ʻē aʻe ma ko lākou mau home ma mua o nā ʻōpio. Akā, ʻoi aku ka liʻiliʻi o nā keiki liʻiliʻi ma mua o nā ʻōpio e hoʻolauna i ka maʻi. No ka hiki ʻana i kēia hopena, ua kālailai nā mea noiʻi i ka ʻikepili i nā hoʻokolohua maikaʻi a me o nā hihia COVID-19 ma ka ʻāina ʻo Ontario ma waena o Iune 1 a me Dekemaba 31, 2020, a ua ʻike ʻoi aku ma mua o 6 mau hale kahi i loaʻa ai ka maʻi mua ma lalo o ka makahiki 200. ka hoao maikai o ke keiki mua.

ʻOi aku ka maʻi lele ʻana o nā keiki liʻiliʻi no ka mea ʻoi aku ka paʻakikī o ka hoʻokaʻawale ʻana

Ua ʻike ʻia he 27,3% o nā keiki i maʻi ʻia ma kahi o hoʻokahi kanaka ʻē aʻe mai ka hale hookahi. ʻO ka poʻe ʻōpio he 38% o nā hihia mua a pau ma nā hale, hoʻohālikelike ʻia me 12% o nā keiki i piha i ka makahiki 3 a ma lalo. Akā ʻo ka pilikia o ka hoʻouna ʻana i nā ʻohana ʻē aʻe he 40% kiʻekiʻe i ka wā ʻo ke keiki maʻi mua he 3 mau makahiki a ʻoi aku paha ma mua o kona mau makahiki he 14 a 17. Hiki ke wehewehe ʻia kēia mau hopena ma muli o ke koi ʻana o nā keiki liʻiliʻi i ka mālama pono a ʻaʻole hiki ke hoʻokaʻawale ʻia ke maʻi lākou, ʻōlelo ka poʻe noiʻi. Eia kekahi, i ka wā he "jack-of-all-trades" nā keiki, he paʻakikī ke hana iā lākou e hoʻopaʻa i nā hana pale.

"ʻO ka poʻe i hānai keiki ʻōpio maʻa i ka loaʻa ʻana o ka sputum a me ka drooling ma ka poʻohiwi. “Ua haʻi aku ʻo Dr. Ua haʻi ʻo Susan Coffin, he loea maʻi maʻi maʻi ma ka Halemai o nā keiki ma Philadelphia, i ka New York Times. "ʻAʻohe mea e hoʻopuni ai. Akā, e hoʻohana i nā ʻiʻo i hoʻopau ʻia, e holoi koke i kou mau lima ma hope o ke kōkua ʻana iā lākou e holoi i ko lākou ihu, he mau mea hiki i ka makua o kahi keiki maʻi ke hana i mea e kaupalena ai ka laha ʻana o ka maʻi maʻi i loko o ka hale. Inā ʻaʻole pane ka haʻawina i nā nīnau o nā keiki maʻi pū kekahi lele ma mua o nā mākua, hōʻike kēia i nā keiki liʻiliʻi ke kuleana kūikawā i ka lawe ʻana i ka maʻi.

"Ke hōʻike nei kēia haʻawina e ʻoi aku ka nui o nā keiki liʻiliʻi e hoʻoili i ka maʻi ma mua o nā keiki nui, ua ʻike ʻia ka pilikia kiʻekiʻe o ka hoʻouna ʻana i nā makahiki 0 a 3 mau makahiki. », Hoʻopau nā mea noiʻi. He mea nui kēia ʻike, no ka mea, ʻoi aku ka maikaʻi o ka hoʻomaopopo ʻana i ka pilikia o ka lawe ʻana i ka maʻi maʻi e like me hui makahiki pediatric he mea pono no ka pale ʻana i ka maʻi i loko o nā maʻi ʻino. Akā i loko o nā kula a me nā hale mālama lā, i mea e hōʻemi ai i ka hopena o ka hoʻouna kiʻekiʻe ma nā ʻohana. Kāhea ka hui ʻepekema i nā noiʻi hou aʻe e pili ana i kahi hui nui aʻe o na keiki o na makahiki like ole e hoʻokumu i kēia pilikia i ʻoi aku ka pololei.

ʻO Covid-19 a me ka maʻi inflammatory i nā keiki: wehewehe kahi haʻawina i ka hanana

I nā hihia liʻiliʻi loa i nā keiki, ua alakaʻi ʻo Covid-19 i ka multisystem inflammatory syndrome (MIS-C a i ʻole PIMS). Ma kahi noiʻi hou, hāʻawi nā mea noiʻi i ka wehewehe ʻana no kēia ʻano ʻike ʻole ʻole ʻia.

ʻO ka mea pōmaikaʻi, ʻo ka hapa nui o nā keiki i loaʻa i ka Sars-CoV-2 coronavirus e hoʻomohala i nā hōʻailona liʻiliʻi, a i ʻole asymptomatic. kulina i nā hihia liʻiliʻi loa, ua ulu ʻo Covid-19 i nā keiki i ka maʻi ʻeha multisystemic (MIS-C a i ʻole PIMS). Inā mākou i kamaʻilio mua e pili ana i ka maʻi Kawasaki, ʻoiaʻiʻo he maʻi maʻi kūikawā, e kaʻana like ana i kekahi mau ʻano me ka maʻi Kawasaki akā ʻokoʻa naʻe.

Ma ke ʻano he hoʻomanaʻo, ʻike ʻia ka multisystem inflammatory syndrome e ʻO nā hōʻailona e like me ke kuni, ka ʻeha o ka ʻōpū, ka ʻūhā, ka naʻau a me nā pilikia neurological e hiki mai ana 4 a 6 mau pule ma hope. ka maʻi me Sars-CoV-2. ʻIke mua ʻia, hiki ke mālama ʻia kēia maʻi me ke kōkua o nā immunosuppressants.

Ma kahi noiʻi ʻepekema hou i paʻi ʻia ma Mei 11, 2021 ma ka puke pai Immunity, ua ho'āʻo ka poʻe noiʻi ma ke Kulanui o Yale (Connecticut, USA) e hoʻomālamalama keia hanana o ka immune overreaction.

Ua nānā ka hui noiʻi i nā koko koko mai nā keiki me MIS-C, nā pākeke me kahi ʻano koʻikoʻi o Covid-19, a me nā keiki olakino a me nā pākeke. Ua ʻike ka poʻe noiʻi ua loaʻa i nā keiki me MIS-C nā ʻano kūlohelohe ʻokoʻa mai nā hui ʻē aʻe. Ua loaʻa iā lākou nā pae kiʻekiʻe o nā alarmines, nā molekala o ka ʻōnaehana immune innate, i hoʻoneʻe koke ʻia e pane i nā maʻi āpau.

« Hiki ke ʻoi aku ka ikaika o ka innate immunity i nā keiki i loaʻa i ka maʻi maʻi "wahi a Carrie Lucas, ke kaukaʻi o ka immunology a me ka mea kākau o ka noiʻi. ” Akā ma ka ʻaoʻao ʻē aʻe, i nā hihia liʻiliʻi, hiki ke hauʻoli nui a kōkua i kēia maʻi ʻeha. », Ua hoʻohui ʻo ia i kahi kamaʻilio ʻia.

Ua ʻike pū nā mea noiʻi ua hōʻike nā keiki me MIS-C i nā kiʻekiʻe i hōʻailona ʻia i kekahi mau pane kūlohelohe adaptive, nā pale e hakakā i nā pathogens kūikawā - e like me nā coronaviruses - a e hāʻawi maʻamau i ka hoʻomanaʻo immunological. Akā ma kahi o ka pale ʻana, ʻike ʻia nā pane kūlohelohe o kekahi mau keiki e hoʻouka i nā ʻiʻo i loko o ke kino, e like me ke ʻano o nā maʻi autoimmune.

No laila, i nā hihia kakaʻikahi loa, ʻO ka pane palekana o nā keiki e hoʻomaka ana i kahi cascade o nā hopena e hōʻino i ka ʻiʻo olakino. A laila lilo lākou i mea palupalu i nā hoʻouka autoantibody. Manaʻo ka poʻe noiʻi e hāʻawi kēia ʻikepili hou i ka ʻike mua a me ka hoʻokele maikaʻi ʻana o nā keiki i ka pilikia nui o ka hoʻomohala ʻana i kēia hoʻopiʻi o Covid-19.

Covid-19: ʻae ʻia nā hoʻāʻo swab ihu no nā keiki

Ua hāʻawi ka Haute Autorité de Santé i ke kukui ʻōmaʻomaʻo i ka hoʻolaha ʻana i nā hoʻokolohua antigenic e ka nasal swab no nā keiki ma lalo o 15 mau makahiki. Pono kēia hoʻonui i ka muli loa e hoʻonui nui i ka nānā ʻana i nā kula, mai ke kula kindergarten.

ʻO nā hoʻokolohua antigenic ma ka nasal swab, me nā hopena wikiwiki, ua ʻae ʻia i kēia manawa no nā keiki ma lalo o 15. ʻO kēia ka mea a ka Haute Autorité de Santé (HAS) i hoʻolaha wale ai ma kahi hoʻolaha. No laila e hoʻohana ʻia kēia mau hoʻāʻo no ka nānā ʻana no Covid-19 i nā kula, me nā hoʻāʻo saliva, kahi mea hana hou no ka nānā ʻana no Covid-19 ma waena o nā ʻōpio.

No ke aha kēia hoʻololi i ka hoʻolālā?

Selon ka HAS, "ʻO ka nele o nā haʻawina i nā keiki ua alakaʻi i ka HAS e kaupalena (ka hoʻohana ʻana i nā hoʻāʻo antigenic a me nā hoʻāʻo ponoʻī) i ka poʻe ma mua o 15 mau makahiki". Eia naʻe, ʻoiai ua hoʻokō ʻia nā haʻawina hou, ke ulu nei ka hoʻolālā screening. "ʻO kahi meta-analysis i hana ʻia e ka HAS e hōʻike ana i nā hopena hoʻoikaika i nā keiki, i kēia manawa hiki ke hoʻonui i nā hōʻailona a noʻonoʻo i ka hoʻohana ʻana i nā hoʻāʻo antigenic ma nā laʻana ihu i nā kula. Me ka hopena ma 15 a 30 mau minuke, ua lilo lākou i mea hoʻohui i nā hoʻāʻo RT-PCR salivary e uhaʻi i nā kaulahao o ka palaka i loko o nā papa., hoike mai ka HAS.

No laila, pono e kau ʻia nā hoʻokolohua nasal swab ma kahi ākea ma na kula "Ma loko o nā kula hānai a me nā kula haʻahaʻa, nā koleke, nā kula kiʻekiʻe a me nā kulanui, ma waena o nā haumāna, nā kumu a me nā limahana e pili ana me nā haumāna", kuhikuhi i ka HAS.

ʻO ka pū o kēia mau ho'āʻo antigenic: ʻaʻole lākou i hoʻouna ʻia i kahi keʻena hana, a ʻae i ka nānā wikiwiki ʻana, ma ka pūnaewele, i loko o 15 a 30 mau minuke. ʻAʻole liʻiliʻi lākou i ka invasive a emi ʻole ka ʻeha ma mua o ka hoʻāʻo PCR.

Nā ho'āʻo antigenic mai ke kula kindergarten

ʻO ka ʻoiaʻiʻo, pehea e hana ai kēia? Wahi a nā ʻōlelo aʻoaʻo HAS, “Hiki i nā haumāna, ke kula kiʻekiʻe a me nā haumāna kulanui ke hana i ka hoʻāʻo ponoʻī iā lākou iho (ma hope o ka hana mua ma lalo o ka mākaʻikaʻi ʻana o ke kanaka makua mākaukau inā pono). No nā haumāna kula haʻahaʻa, Hiki nō hoʻi ke hoʻāʻo ponoʻī ʻia ma mua, akā ʻoi aku ka maikaʻi o ka hoʻāʻo ʻana e nā mākua a i ʻole nā ​​limahana i aʻo ʻia. No nā keiki ma ke kula kindergarten, pono e hana ʻia ka laʻana a me ka hoʻāʻo e kēia mau mea hana like. “ E hoʻomanaʻo i ke kula hānai, nā hoʻāʻo ʻana o ka saliva hoʻomaʻamaʻa pū ʻia.

ʻO kēlā me kēia hoʻāʻo screening i hana ʻia, e mau ana malalo o ka mana makua no na kamalii.

Source: Press release: “Covid-19: hoʻokiʻekiʻe ka HAS i ka palena makahiki no ka hoʻohana ʻana i nā hoʻokolohua antigenic ma kahi swab ihu "

ʻO ka hoʻāʻo pilikino Covid-19: nā mea āpau e pili ana i kā lākou hoʻohana, ʻoi aku i nā keiki

Hiki iā mākou ke hoʻohana i kahi hoʻāʻo ponoʻī e ʻike iā Covid-19 i kā mākou keiki? Pehea ka hana ana o na hoao ana iho? Ma hea e loaʻa ai? Lawe mākou i ka waihona.

Kūʻai ʻia nā hoʻāʻo ponoʻī ma nā hale kūʻai. Ke alo nei i ka piʻi ʻana o ka maʻi ahulau, hiki ke hoʻowalewale i ka hoʻokō ʻana i hoʻokahi a ʻoi aku paha, ʻoi aku ka hōʻoluʻolu iā ʻoe iho.

ʻO ka hoʻāʻo pilikino Covid-19: pehea e hana ai?

ʻO nā hoʻāʻo ponoʻī i kūʻai ʻia ma Farani he mau hoʻāʻo antigenic, kahi e hiki ai ke hoʻokō wale ʻia ka laʻana a me ka heluhelu ʻana i ka hopena, me ka ʻole o ke kōkua olakino. Hana ʻia kēia mau hoʻokolohua ma o he la'ana ihu. Hōʻike nā ʻōlelo kuhikuhi he nīnau ia o ka hoʻokomo ʻana i ka swab i loko o kahi puka ihu ma luna o 2 a 3 knm me ka ʻole o ka hoʻoikaika ʻana, a laila e hoʻoluli mālie iā ia a hoʻokomo liʻiliʻi a hiki i ka loaʻa ʻana o kahi kūʻē iki. Ma laila, pono ia e hoʻohuli i loko o ka puka ihu. ʻOi aku ka pāpaʻu o ka laʻana ma mua o ka laʻana nasopharyngeal i hana ʻia i ka wā PCR maʻamau a me nā hoʻāʻo antigen, i hana ʻia i loko o ka hale hana a i ʻole kahi lāʻau lapaʻau.

He wikiwiki ka hopena, a ʻike ʻia e like me ka hoʻāʻo hāpai ʻana, ma hope o 15 a 20 mau minuke.

No ke aha e hana ai i kahi hoʻokolohua Covid?

Hoʻohana ʻia ka nasal self-test no ka ʻike ka poʻe ʻaʻohe hōʻailona a ʻaʻole pili. Hiki iā ʻoe ke ʻike inā he mea lawe ʻoe iā Sars-CoV-2 a ʻaʻole paha, akā makemake wale ia inā hana mau ʻia, kēlā me kēia ʻelua a ʻekolu mau lā, e kuhikuhi i nā ʻōlelo kuhikuhi.

Inā loaʻa iā ʻoe nā hōʻailona a i ʻole pili ʻoe me kahi kanaka i hōʻike maikaʻi ʻia, pono ʻoe e hoʻohana i kahi hoʻokolohua PCR maʻamau, ʻoi aku ka hilinaʻi. Ma muli o ka loaʻa ʻana o kahi hopena maikaʻi i ka hoʻāʻo ponoʻī pono e hōʻoia i ka maʻi maʻi e PCR.

Hiki ke hoʻohana ʻia nā hoʻāʻo ponoʻī i nā keiki?

Ma kahi manaʻo i hoʻopuka ʻia ma ka lā 26 ʻApelila, ʻōlelo ka Haute Autorité de Santé (HAS) i ka hoʻohana ʻana i nā hoʻāʻo ponoʻī no ka poʻe ma lalo o 15 mau makahiki.

Inā loaʻa nā hōʻailona hōʻailona o Covid-19 a hoʻomau i ke keiki, ʻoi aku ka nui o ke kuni, ʻoi aku ka maikaʻi e hoʻokaʻawale i ke keiki a nīnau i kahi kauka lapaʻau a i ʻole ka pediatrician, nāna e hoʻoholo i ka pono e hana i kahi hoʻokolohua. ka nānā ʻana no Covid-19 (PCR a i ʻole antigen, a i ʻole kohu inā ʻoi aku ka liʻiliʻi o ke keiki ma mua o 6 mau makahiki). He mea nui ka hoʻokolokolo kino i ʻole e poina i kahi maʻi koʻikoʻi o ke keiki, e like me ka maʻi maʻi.

No laila ʻoi aku ka maikaʻi o ka pale ʻana i ka hoʻāʻo ʻana iā ia iho ma nā koina āpau, ma ka liʻiliʻi loa i nā keiki. Ma hope o nā mea a pau, hoʻomau ka ʻano o ka laʻana i ka invasive a paʻakikī paha ke hana pololei i nā keiki liʻiliʻi.

[Ma ka hōʻuluʻulu manaʻo]

• ʻO ka holoʻokoʻa, ʻaʻole liʻiliʻi nā keiki a me nā pēpē e ka Sars-CoV-2 coronavirus, a i ka wā e ulu ai lākou. ʻano koʻikoʻi liʻiliʻi ma mua o nā mākua. Hōʻike palapala ʻepekema asymptomatic a ʻaʻole hōʻailona loa i na keiki, pinepine, me ʻōuli mālie (ke anu, ke kuni, ka ma'i digestive ma ka nui). I nā pēpē, ʻoi aku ka nui o ka welaka mea i hoʻomalu, ke hoʻomohala lākou i kahi ʻano hōʻailona.
• I nā hihia liʻiliʻi loa, hiki i ka Covid-19 i nā keiki ke kumu multisystem inflammatory syndrome, MIS-C, aloha kokoke i ka maʻi Kawasaki, hiki ke hoʻopilikia i nā aʻa coronary. ʻO ke koʻikoʻi, hiki ke mālama ʻia kēia maʻi ma ka mālama koʻikoʻi a alakaʻi i kahi hoʻōla piha.
• ʻO ka pilikia o ka lawe ʻana i ka coronavirus Sars-CoV-2 i nā keiki ke kumu o ka hoʻopaʻapaʻa a me kekahi mau noiʻi me nā hopena hakakā. Me he mea lā naʻe, ke puka mai nei ka manaʻo ʻepekema, a ʻo iaa priori liʻiliʻi nā keiki i ka maʻi maʻi ma mua o nā mākua. E hoʻohaumia ʻia lākou ma ka ʻaoʻao pilikino ma mua o ke kula, ʻoi aku ka nui o nā masks a me nā hana pale i nā kula.
• E like me ka ho'āʻo ai i e ʻike i ka hele ʻana o ka coronavirus, ka hoʻāʻo antigen ua ʻae ʻia i kēia manawa i nā keiki ma lalo o 15 mau makahiki, i loko o lākou a me nā hoʻāʻo ʻana i ka saliva,  
• The n'existe a priori ʻaʻohe contraindication i ka hoʻopaʻa ʻana i nā keiki. ʻO nā hoʻokolohua i hana ʻia e Pfizer a me BioNTech e loaʻa i ka pale kūpono mai ka coronavirus i nā keiki. Ma mua o ka hoʻopaʻa ʻana i nā keiki, pono e loaʻa i nā laboratories ka ʻaelike o nā mana hoʻoponopono like ʻole a puni ka honua.

Hoʻokuʻu ʻo AstraZeneca i nā hoʻāʻo ʻana i ka maʻi maʻi Covid i nā keiki

Inā hoʻolaha ʻo Pfizer & BioNTech i ka 100% pono o kāna kano i ka poʻe ʻōpio mai 12 a 15 mau makahiki, no ka manawa e hoʻōki ai ʻo AstraZeneca i kāna mau hoʻāʻo ma ka muli loa. Lawe mākou i ka waihona.

Nā ho'āʻo lāʻau lapaʻau, lawe ʻia ma luna o nā mea ʻoi aku 2 200 opio ma ʻAmelika Hui Pū ʻIa, e hōʻike i ka 100% efficacy o ka Pzifer-BioNTech vaccine i nā makahiki 12-15. No laila hiki iā lākou ke hoʻopaʻa ʻia ma mua o ka hoʻomaka ʻana o ka makahiki kula i Kepakemapa 2021.

He hoʻomaka i Pepeluali

No kona ʻāpana. ʻO nā hale hana ʻo AstraZeneca ua hoomaka no hoi nā hoʻokolohua lapaʻau Feberuari i hala, ma United Kingdom, ma 240 mau keiki mai 6 a 17 makahiki, i hiki ke hoʻomaka i kahi lāʻau lapaʻau anti-Covid o ka muli loa ma mua o ka hopena o 2021.

Hoʻokolo ʻia nā hoʻokolokolo

Ma ka lā Malaki 24, ma United Kingdom, 30 mau hihia o ka thrombosis i loaʻa i nā pākeke ma hope o ka hoʻopaʻa ʻana me AstraZeneca. Ma waena o kēia mau hihia, 7 mau kānaka i make.

Mai ia manawa, ua hoʻomaha loa kekahi mau ʻāina i ka hoʻopaʻa ʻana me kēia huahana (Norway, Denmark). ʻO nā mea ʻē aʻe e like me Farani, Kelemānia, Kanada, hāʻawi wale iā ia mai ka makahiki 55 a i ʻole 60, e pili ana i ka ʻāina.

ʻO ia ke kumu e paʻa ai nā hoʻokolohua lapaʻau i nā keiki Pelekane. Ke kali nei ke Kulanui o Oxford, kahi i hana ʻia ai kēia mau hoʻokolohua, i ka hoʻoholo a nā luna e ʻike inā hiki paha ke hoʻomau iā lākou.

I kēia manawa, pono e hoʻomau nā keiki i komo i ka hoʻokolohua lapaʻau AstraZeneca e hele i nā kipa i hoʻonohonoho ʻia.

Covid-19: Hoʻolaha ʻo Pfizer a me BioNTech he 100% maikaʻi kā lākou kano i nā makahiki 12-15.

Wahi a nā laboratories Pfizer a me BioNTech, hāʻawi kā lākou lāʻau lapaʻau i nā pane antibody ikaika e kūʻē iā Covid-19 i nā ʻōpio makahiki 12 a 15. ʻO ka kikoʻī. 

Le Kano Pfizer & BioNTech ʻo ia ka lāʻau lapaʻau mua e kūʻē iā Covid-19 i ʻae ʻia ma ka hopena o 2020. A hiki i kēia manawa, ua ʻae ʻia ka hoʻohana ʻana no nā poʻe 16 a ʻoi aku. Hiki ke hoʻololi i kēia ma hope o nā hoʻokolohua lapaʻau pae 3 i hana ʻia.

100% pono

maika nā hoʻokolohua lapaʻau ua hana ʻia ma ka ʻoiaʻiʻo 2 260 opio ma USA. Ua hōʻike lākou i kahi 100% pono kano kūʻē iā Covid-19, me ka ʻano Pelekane o ka maʻi.

Hana ʻia ma mua o Kepakemapa?

Ma hope o nā makahiki 12-15, ua hoʻomaka ka hale hana nā hoʻokolohua ma nā keiki liʻiliʻi: 5 a 11 mau makahiki. A mai keia pule aku, o ka manawa ia o na kamalii. mai 2 a 5 makahiki.

No laila, manaʻolana ʻo Pfizer-BioNTech e hiki ke hoʻomaka ka hoʻopaʻa ʻana i nā keiki a me nā ʻōpio ma mua o ka makahiki kula e hiki mai ana i Kepakemapa 2021. No ka hana ʻana i kēia, pono lākou e kiʻi mua i ka ʻaelike o nā mana hoʻoponopono like ʻole a puni ka honua.

ʻEhia mau lāʻau lapaʻau?

I kēia lā, ua hāʻawi ʻo Pfizer-BioNTech i 67,2 miliona mau kano o kāna kano ma ʻEulopa. A laila, i ka lua o ka hapaha, he 200 miliona mau doses.

Covid-19: I ka manawa hea e hoʻāʻo ai kaʻu keiki?

ʻOiai ʻaʻole nāwaliwali ka maʻi maʻi Covid-19, ke kahaha nei nā mākua. Pono ʻoe e hoʻāʻo i kāu keiki no ke anu liʻiliʻi? He aha nā hōʻailona e manaʻo ai kekahi iā Covid-19? I ka wa hea e kukakuka ai me ka mai kuni a me ke kunu? Hōʻike hou me Professor Delacourt, pmea hoʻoponopono ma ka Necker Sick Children Hospital a me ka Pelekikena o ka French Pediatric Society (SFP).

ʻAʻole maʻalahi ka hoʻokaʻawale ʻana i nā hōʻailona o ke anu, ka bronchitis, mai nā Covid-19. ʻO kēia ke kumu o ka hopohopo o nā mākua, a me ka nui o nā kipaku kula no nā keiki.

Ke hoʻomanaʻo nei i nā hōʻailona o ka maʻi me ka coronavirus hou (Sars-CoV-2) maʻamau loa i nā keiki, kahi a mākou e nānā ai. liʻiliʻi nā ʻano koʻikoʻi a me nā ʻano asymptomatic he nui, Ua hoike mai o Professor Delacourt i kela ʻo ke kuni, nā maʻi hoʻoheheʻe ʻana a me nā maʻi hanu i kekahi manawa ʻo nā hōʻailona nui o ka maʻi i loko o ke keiki. “Ke loaʻa nā hōʻailona (ke kuni, ka ʻeha hanu, ka ʻū, nā pilikia digestive, ka ʻōlelo a ka mea hoʻoponopono) a loaʻa ka pilina me kahi hihia i hōʻoia ʻia, pono e nīnau a hoʻāʻo ʻia ke keiki.”, Hōʻike ʻo Professor Delacourt.

Inā loaʻa nā hōʻailona, ​​​​"maikai e hoʻihoʻi i ke keiki mai ke kaiāulu (kula, kahu hānai, kahu hānai) inā loaʻa ke kānalua, a e ʻimi i ka ʻōlelo aʻo kino. “

COVID-19: ʻo ka ʻōnaehana pale o nā keiki e pale iā lākou mai kahi maʻi koʻikoʻi

Ua hōʻike ʻia kahi noiʻi i paʻi ʻia ma Pepeluali 17, 2021 e ʻoi aku ka palekana o nā keiki mai ka COVID-19 koʻikoʻi ma mua o nā pākeke no ka mea. ʻoi aku ka wikiwiki o kā lākou ʻōnaehana pale kino ka coronavirus ma mua o ka hana hou ʻana i ke kino.

Ma muli o ka liʻiliʻi pinepine a me ka liʻiliʻi o ka hopena e SARS-CoV-2 ma mua o nā pākeke, paʻakikī ka loaʻa ʻana o ka ʻike e pili ana iā Covid-19 i nā keiki. ʻElua mau nīnau e puka mai ana mai kēia mau ʻike epidemiological: no ke aha i emi iki ai na keiki et No hea mai kēia mau kikoʻī? He mea nui kēia ma muli o ka noiʻi ʻana i nā keiki e ʻae i ka holomua o nā pākeke: ʻo ia ka hoʻomaopopo ʻana i ka mea e hoʻokaʻawale ai i ka ʻano o ka maʻi a i ʻole ka pane ʻana o ke kino e like me ka makahiki e hiki ai ke "ʻike i nā mīkini e ʻimi ai. ʻO nā mea noiʻi ma ka Murdoch Institute for Research on Children (Australia) i hoʻopuka i kahi kuhiakau.

ʻO kā lākou aʻo ʻana, e pili ana i ka nānā ʻana i nā laʻana koko mai 48 mau keiki a me 70 mau mākua, a paʻi ʻia i loko o ka puke moʻolelo ʻepekema Nature Communications, ʻōlelo ʻia e lilo nā keiki. ʻoi aku ka maikaʻi o ka pale ʻana i nā ʻano koʻikoʻi o COVID-19 no ka mea, ʻo kā lākou ʻōnaehana pale kino hoʻouka koke i ka maʻi maʻi. Ma nā huaʻōlelo koʻikoʻi, ʻoi aku ka wikiwiki o nā kelepona kūikawā o ka ʻōnaehana pale o ke keiki i ka SARS-CoV-2 coronavirus. Manaʻo ka poʻe noiʻi ʻo nā kumu i loaʻa ai i nā keiki ka maʻi maʻi COVID-19 i hoʻohālikelike ʻia me nā pākeke a ʻaʻole ʻike ʻia nā ʻōnaehana pale i lalo o kēia pale a hiki i kēia noiʻi.

Maʻalahi pinepine nā hōʻailona i nā keiki

« ʻAʻole liʻiliʻi ka maʻi ʻana o nā keiki i ka maʻi a hiki i ka hapakolu o lākou he asymptomatic, ʻokoʻa loa ia mai ka maʻi maʻi kiʻekiʻe a me ke koʻikoʻi i ʻike ʻia no ka hapa nui o nā maʻi hanu ʻē aʻe.wahi a Kauka Melanie Neeland, nāna i alakaʻi i ke aʻo ʻana. ʻO ka hoʻomaopopo ʻana i nā ʻokoʻa e pili ana i ka makahiki i ka paʻakikī o Covid-19 e hāʻawi i ka ʻike koʻikoʻi a me nā mea hiki ke pale a me ka mālama ʻana, no Covid-19 a no nā maʻi maʻi e hiki mai ana. Ua maʻi ʻia a ʻike ʻia paha nā poʻe āpau i ka SARS-CoV-2, a ua nānā ʻia kā lākou mau pane kūlohelohe i ka wā o ka maʻi maʻi a hiki i ʻelua mahina ma hope.

Ma ke ʻano he ʻohana me nā keiki ʻelua, maikaʻi no ka coronavirus, ua ʻike nā mea noiʻi ʻO nā kaikamahine ʻelua, 6 a me 2 mau makahiki, he ihu liʻiliʻi ko lākou, ʻoiai ua loaʻa nā mākua i ka luhi loa, ke poʻo, ka ʻeha ʻiʻo, a me ka pau ʻana o ka ʻai a me ka ʻono. He ʻelua pule ka lōʻihi o ko lākou ola ʻana. No ka wehewehe ʻana i kēia ʻokoʻa, ua ʻike nā mea noiʻi ua ʻike ʻia ka maʻi i nā keiki ka hoʻoulu ʻana o nā neutrophils (ke koko keʻokeʻo e kōkua ana i ka hoʻōla ʻana i ka ʻiʻo i hōʻino ʻia a hoʻoponopono i nā maʻi), a ma ka hōʻemi ʻana i ka pane mua ʻana o nā cell immune, e like me nā mea pepehi maoli i loko o ke koko.

ʻO kahi pane ʻoi aku ka maikaʻi

« Hōʻike kēia i ka neʻe ʻana o kēia mau cell immune e hakakā nei i ka maʻi i nā wahi o ka maʻi, e hoʻopau koke i ka maʻi ma mua o ka loaʻa ʻana o ka manawa e paʻa maoli ai. Hoʻohui ʻo Dr Melanie Neeland. Hōʻike kēia i ka ʻōnaehana immune innate, kā mākou laina mua o ka pale ʻana i nā germs, he mea koʻikoʻi i ka pale ʻana i ka COVID-19 i nā keiki. ʻO ka mea nui, ʻaʻole i hoʻopiʻi ʻia kēia ʻano hoʻōla i ka poʻe mākua i ke aʻo ʻana. Ua hoihoi pū ʻia ka hui ʻepekema i ka ʻike ʻana i nā keiki a me nā pākeke i ʻike ʻia i ka coronavirus, akā ʻo ka nānā ʻana i ka maikaʻi ʻole, ua hoʻololi ʻia nā pane o ka immune.

Wahi a nā mea noiʻi, " Ua piʻi ka helu neutrophil i nā keiki a me nā pākeke a hiki i ʻehiku mau pule ma hope o ka hoʻolaha ʻana i ka maʻi maʻi, hiki ke hāʻawi i kahi pae palekana i ka maʻi. “. Ua hōʻoia kēia mau ʻike i nā hopena o kahi noiʻi mua i hana ʻia e ka hui like i hōʻike ʻia he ʻekolu mau keiki mai ka ʻohana Melbourne i hoʻomohala i kahi pane kūlohelohe like ma hope o ka lōʻihi o ka hoʻolaha ʻana i ka coronavirus mai ko lākou mau mākua. ʻOiai ua loaʻa kēia mau keiki i ka SARS-CoV-2, ua hoʻomohala lākou i kahi pane kūlohelohe maikaʻi loa e pale ai i ka maʻi mai ka hana hou ʻana, ʻo ia ka mea. ʻaʻole loa i loaʻa kahi hoʻokolohua hōʻoia maikaʻi.

Hōʻike ʻia nā hōʻailona ʻili i nā keiki

Ua haʻi ka National Union of Dermatologists-Venereologists i nā hōʻike hiki ke loaʻa ma ka ʻili.

« I kēia manawa, ʻike mākou i nā keiki a me nā mākua i ka ʻulaʻula o nā ʻoki a i kekahi manawa nā ʻōhū liʻiliʻi ma nā lima a me nā wāwae, i ka wā o kahi maʻi maʻi COVID. ʻAʻole maʻamau kēia puka ʻana o ka mea e like me ka frostbite a hui pū me ka pilikia maʻi maʻi COVID. He ʻano liʻiliʻi paha ia o ka maʻi COVID, he hōʻike lohi paha ma hope o ka maʻi i ʻike ʻole ʻia, a i ʻole he maʻi ʻē aʻe ma mua o COVID e hiki mai ana i ka manawa like me ke ahulau o kēia manawa. Ke hoʻāʻo nei mākou e hoʻomaopopo i kēia ʻano », Wehewehe ʻo Professor Jean-David Bouaziz, dermatologist ma Saint-Louis Hospital.

ʻO Coronavirus: he aha nā pilikia a me nā pilikia no nā keiki?

Ma waho aʻe o nā mea maʻi i loaʻa i ka maʻi a ua ola hou, ʻaʻohe mea i pale maoli i ka maʻi me ka coronavirus hou. I nā huaʻōlelo ʻē aʻe, hiki i nā heluna a pau, me nā pēpē, nā keiki a me nā wahine hāpai, hiki ke loaʻa i ka maʻi maʻi.

Eia naʻe, e like me ka ʻikepili i loaʻa, ʻoi aku ka mālama ʻia o nā keiki. ʻAʻole i hoʻopilikia ʻia lākou, a i ka wā i loaʻa ai iā Covid-19, loaʻa iā lākou ʻano maikaʻi. Ke loaʻa nā pilikia i ka poʻe ʻōpio, pili pinepine lākou i nā kumu ʻē aʻe. ʻO kēia ka mea a nā kauka i kapa ai he "comorbidity", ʻo ia hoʻi, ke kū ʻana o nā mea pilikia e pili ana i kekahi pathology.

ʻO nā hoʻopiʻi koʻikoʻi e pili ana iā Covid-19 kakaʻikahi loa i nā keiki a me nā ʻōpio. Akā ʻaʻole lākou i hoʻokaʻawale ʻia, no ka mea, ʻo ka make i loaʻa i kekahi o lākou mai ka hoʻomaka ʻana o ka maʻi maʻi he mau hoʻomanaʻo ʻeha.

Ma kahi ʻatikala ma Le Parisien, ua hoʻomanaʻo ʻo Kauka Robert Cohen, kauka o nā pediatrics, i kēlā me kēia makahiki, "oʻAʻole ʻike ʻia ke kumu o ka holomua maikaʻi ʻole o kēia mau maʻi. ʻAʻole hiki ke ʻike ʻia nā maʻi lele i kekahi manawa akā kakaikahi loa. Ua ʻike ʻoe i kēlā me kēia makahiki make nā keiki i ka maʻi maʻi, ka maʻi ʻaʻai a me ka moa ".

He aha ka MIS-C, ka maʻi hou e pili ana iā Covid-19 e pili ana i nā keiki?

Me ka hoʻomaka ʻana o Covid-19, ua puka mai kekahi maʻi e pili ana i nā keiki. Kokoke i ka ma'i Kawasaki, he okoa nae.

Kapa ʻia ʻo ia i kekahi manawa ʻo PIMS, i kekahi manawa MISC… Ke hoʻomanaʻo nei i ka maʻi Kawasaki, kēia maʻi i hoʻopilikia ʻia ma kahi o hoʻokahi kaukani keiki a puni ka honua mai ka maʻi maʻi Covid he mea hoihoi i nā mea noiʻi. Ua kapa ʻia ʻo ia i kēia manawa multisystem inflammatory syndrome i nā keiki, a i ʻole MIS-C.

E ʻike ʻia ka MIS-C ma kahi o 1 mahina ma hope o ka maʻi me Covid-19

Wahi a nā haʻawina ʻelua, i paʻi ʻia i ka Pōʻakahi, Iune 29, 2020 ma ka " ʻO ka nūpepaʻo New England Journal of Medicine », Hōʻike ʻia nā hōʻailona o kēia maʻi i kekahi mau pule ma hope o ka maʻi me ka maʻi SARS-CoV-2, he median o 25 mau lā e like me ka noiʻi mua ʻana o ʻAmelika. ʻO kahi noiʻi ʻē aʻe i hana ʻia ma New York e kū nei no hoʻokahi mahina ma hope o ka hoʻopōʻino mua ʻana.

MIS-C ma muli o Covid-19: ʻoi aku ka nui o ka pilikia e like me ka lāhui?

Hoʻopaʻa mau ʻia ka maʻi ma ke ʻano he kakaikahi loa: 2 mau hihia ma 100 poʻe ma lalo o ka makahiki 000. Ua ʻike nā mea noiʻi ma nā haʻawina ʻelua ua ʻoi aku ka ʻeleʻele o nā keiki i hoʻopilikia ʻia, ʻo Hispanic, a i ʻole nā ​​​​keiki hānau India, i hoʻohālikelike ʻia me nā keiki keʻokeʻo.

He aha nā hōʻailona o MIS-C?

ʻO ka hōʻailona maʻamau i kēia noiʻi i nā keiki i hoʻopilikia ʻia ʻaʻole ia ka hanu. Ma luna o 80% o nā keiki i pilikia nā maʻi ʻōpū (ʻeha o ka ʻōpū, nausea a luaʻi paha, ʻeha), a he nui nā mea i ʻike ʻili kino ʻili, ʻoi aku ka poʻe ma lalo o ʻelima. Ua loaʻa i ka maʻi kuni nā mea a pau, ʻoi aku ka nui ma mua o ʻehā a ʻelima mau lā. A ma 80% o lākou, ua hoʻopilikia ʻia ka ʻōnaehana cardiovascular. ʻO 8-9% o nā keiki i hoʻomohala i kahi aneurysm coronary artery.

Ma mua, aia ka hapa nui o nā keiki i ke olakino maikaʻi. ʻAʻole lākou i hōʻike i kekahi kumu pilikia, ʻaʻole hoʻi i kekahi maʻi i loaʻa mua. Ua ʻae ʻia ʻo 80% i ka mālama koʻikoʻi, 20% i loaʻa i ke kākoʻo hanu invasive, a 2% i make.

MIS-C: ʻokoʻa me ka maʻi maʻi Kawasaki

I ka puka mua ʻana o ka maʻi, ua ʻike nā kauka i nā mea like me ka maʻi kawasaki, he ma'i e pili ana i na kamalii a me na kamalii liilii loa. Hoʻokumu ka maʻi hope i ka mumū o nā kīʻaha koko i hiki ke hoʻopilikia i ka puʻuwai. Hōʻoia ka ʻikepili hou he mau mea like ka MIS-C a me Kawasaki, akā ʻo ka maʻi maʻi hou e pili pinepine i nā keiki ʻōpio, a e hoʻoulu ai i ka ʻeha nui.

ʻO ka mea pohihihi e wehewehe ʻia i nā kumu o kēia aloha hou. E hoʻopili ʻia me ka lawa ʻole o ka pane ʻana o ka ʻōnaehana pale.

ʻO nā keiki, "nā mea lawe olakino", a i mālama ʻia mai ka coronavirus?

I ka hoʻomaka ʻana o ka maʻi maʻi coronavirus, ʻaneʻane lawe ʻia nā keiki i nā mea lawe olakino olakino: ʻo ia hoʻi, hiki iā lākou. lawe i ka maʻi me ka loaʻa ʻole o nā hōʻailona o ka maʻi, hoʻouna maʻalahi i ka wā o kā lākou pāʻani ma waena o lākou, a i ko lākou ʻohana. Ua wehewehe kēia i ka hoʻoholo e pani i nā kula a me nā kahu hānai, e pale i ka laha ʻana o ka maʻi maʻi coronavirus. 

Akā ʻo ka mea a mākou i lawe ai no ka maopopo ʻana i kēia lā i nīnau ʻia. ʻO kahi noiʻi hou e hōʻike nei i ka hopena, e hoʻouna nā keiki i ka coronavirus liʻiliʻi. “Hiki i nā keiki, no ka mea ʻaʻole nui nā hōʻailona a loaʻa he haʻahaʻa viral load liʻiliʻi ka lawe ʻana i kēia coronavirus hou ", Kostas Danis, epidemiologist ma Public Health France a me ka mea kākau kumu o kēia noiʻi, haʻi aku iā AFP.

Covid-19, anu, bronchitis: pehea ʻoe e hoʻoponopono ai i nā mea?

Ke kokoke mai nei ka hoʻoilo a ʻoiai ʻaʻole i pau ka maʻi maʻi Covid-19, ke kahaha nei nā mākua. Pono ʻoe e hoʻāʻo i kāu keiki no ke anu liʻiliʻi? He aha nā hōʻailona e manaʻo ai kekahi iā Covid-19? I ka manawa hea e kūkākūkā ai no ke kuni a i ʻole ka ʻāʻī? Hoʻohou me Prof. Delacourt, pediatrician ma ka Necker Children Sick Hospital a me ka Pelekikena o ka French Pediatric Society (SFP).

ʻAʻole maʻalahi ka hoʻokaʻawale ʻana i nā hōʻailona o ke anu, ka bronchitis, mai nā Covid-19. ʻO kēia ke kumu o ka hopohopo o nā mākua, a me ka nui o nā kipaku kula no nā keiki.

Covid-19: he aha ka mea e hana ai i ka hihia o nā hōʻailona i nā keiki?

Ke hoʻomanaʻo nei i nā hōʻailona o ka maʻi me ka coronavirus hou (Sars-CoV-2) maʻamau loa i nā keiki, kahi i liʻiliʻi ai nā ʻano koʻikoʻi a me nā ʻano asymptomatic he nui, ua hōʻike ʻo Professor Delacourt i kēlā. ʻO ke kuni, ka hoʻopaʻapaʻa ʻana, a i kekahi manawa, ʻo ka hanu ʻana ka hōʻailona nui o ka maʻi i loko o ke keiki. "Ke loaʻa nā hōʻailona (ke kuni, ka ʻeha hanu, ka ʻū, nā pilikia digestive, ka leka a ka mea hoʻoponopono) a ua hoʻopili ʻia me kahi hihia i hōʻoia ʻia, pono e nīnau ʻia ke keiki a hoʻāʻo ʻia., hōʻike mai ʻo Professor Delacourt.

Inā loaʻa nā hōʻailona, ​​​​" ʻoi aku ka maikaʻi o ka hoʻihoʻi ʻana i ke keiki mai ke kaiāulu (kula, nursery, nursery assistant) i ka wā e kānalua ai, a e ʻimi i ka ʻōlelo aʻo kino. »

ʻO Coronavirus: liʻiliʻi nā hōʻailona i nā pēpē koe wale ke kuni

Ua ʻōlelo ka poʻe noiʻi ʻAmelika i kahi noiʻi i paʻi ʻia ma Kepakemapa 2020 e loaʻa nā pēpē me COVID-19 i kahi maʻi maʻalahi, i hele pū ʻia me ke kuni. A ʻo kēia ʻoiai ʻo ka hōʻoia ʻana o nā hoʻokolohua screening i ke alo o kahi viral load.

Mai kinohi mai o ke ahulau COVID-19, ʻaʻole pili nui ka maʻi i nā kamaliʻi, no laila he liʻiliʻi nā ʻikepili e noiʻi ai i ka hopena o SARS CoV-2 i kēia heluna kanaka. Akā he haʻawina liʻiliʻi o nā pēpē 18 me ka mōʻaukala olakino koʻikoʻi a paʻi ʻia ma ” ʻO ka Journal of Pediatrics Hāʻawi i nā kikoʻī hōʻoiaʻiʻo. 'Ōlelo nā kauka ma ka Halemai Pediatric o Ann & Robert H. Lurie ma Chicago ua ho'āʻo maikaʻi ʻia nā pēpē ma lalo o 90 mau lā Hana maikaʻi ʻo COVID-19, me ka liʻiliʻi a i ʻole ke komo ʻana o ka hanu, a ua manaʻo pinepine ʻia ke kuni ka hōʻailona nui a i ʻole wale nō.

« ʻOiai he liʻiliʻi loa kā mākou ʻikepilinā kamaliʻi me Covid-19ma ʻAmelika Hui Pū ʻIa, hōʻike kā mākou hopena i ka hapa nui o kēia mau pēpē ʻōuli mālie a ʻaʻole paha i ʻoi aku ka pilikia o ka hoʻomohala ʻana i kahi ʻano koʻikoʻi o ka maʻi e like me ka mea i kūkākūkā mua ʻia ma Kina Wahi a Kauka Leena B. Mithal, ka mea kākau alakaʻi o ka noiʻi. “ ʻO ka hapa nui o nā pēpē i kā mākou aʻo ʻana ua loaʻa i ke kuni, e hōʻike ana i nā pēpē ʻōpioka poe kukakuka no ke kuni, He kumu koʻikoʻi paha ʻo Covid-19, ma nā wahi i kūkulu ʻia ai ka hana kaiāulu. Eia nō naʻe, he mea nui e noʻonoʻo i ka maʻi bacterial i nā pēpē ʻōpio me ke kuni. »

ʻO ke kuni, ka ʻū a me nā hōʻailona o ka ʻōpū, nā hōʻailona manaʻo

Hōʻike ka haʻawina he 9 o kēiaua hoʻokomo ʻia nā pēpē i ka haukapila akā ʻaʻole pono ke kōkua hanu a i ʻole ka mālama koʻikoʻi. Ua ʻae ʻia nā mea hope loa no ka nānā ʻana i ka lāʻau lapaʻau, ka nānā ʻana i ka hoʻomanawanui ʻana i ka meaʻai, ka hoʻoholo ʻana i ka maʻi bacteria me nā lāʻau antibiotic intravenous i nā pēpē ma lalo o 60 mau lā o ka makahiki. Mawaena o keia 9 kamalii, 6 o lakou i hoike mai hōʻailona ʻōpū (ka pau ʻana o ka ʻai, ka luaʻi, ka maʻi ʻaʻai) ma mua o ka ʻaʻa a me ka paʻa o ka ʻōpū hanu luna. ʻEwalu nō hoʻi lākou i hōʻike mai kuni wale no, a ʻehā me ka ʻuʻu a i ʻole ka hanu pulmonary ikaika.

Ma hope o ka hoʻokō ʻana i nā hoʻokolohua no ka ʻike pololei ʻana i ka maʻi me ka hoʻohana ʻana i ka ʻenehana PCR (mai kahi laʻana olaola, ʻo ka pinepine nasopharyngeal), ʻike nā kauka i kēlā.nā kamaliʻi ʻōpio Ua loaʻa i nā puʻupaʻa viral kiʻekiʻe loa i kā lākou mau laʻana, ʻoiai he maʻi maʻi maʻi. ” ʻAʻole maopopo i nā pēpē ʻōpio me ke kuni a me kaua ho'āʻo maikaʻi ʻia no SARS-CoV-2pono i ka halemai Hoʻohui ʻo Dr Leena B. Mithal. ” ʻO ka hoʻoholo e hoʻokomo i ka mea maʻi i ka haukapila e pili ana i ka makahiki, ka pono no ka mālama pale ʻana no ka maʻi bacterial, loiloi loiloi, a me ka hoʻomanawanui ʻana i ka meaʻai. »

Hoʻokahi mea maopopo, akā naʻe: ʻōlelo ka hui ʻepekema e hoʻohana ka nānā wikiwiki ʻana no SARS-CoV-2i kēlā mau maʻi e ola kino ana nā pēpē akā he kuni. Pono e hoʻomaopopo ʻia he nui nā hulina e hana ʻia nei i mea e ʻike ai inā aia kahi loulou ma waena o ka ʻO ka maʻi ʻo Kawasaki a me Covid-19 ʻoiai ua ʻike ʻia ka hōʻiliʻili ʻana o nā hihia ma Farani a ma waho. Wahi a ka Academy of Medicine, he ʻano maʻi ʻokoʻa kēia, no ka mea, ua hui ʻia nā hōʻailona (ka ʻeha o ka ʻōpū koʻikoʻi, nā hōʻailona ʻili) ma lalo o ka inoa o "pediatric multisystem inflammatory syndrome" a me nā makahiki o nā keiki i hoʻopilikia ʻia (9 i ka makahiki 17). ʻoi aku ka kiʻekiʻe ma mua o ke ʻano maʻamau o ka maʻi Kawasaki.

Covid-19: nā kamaliʻi liʻiliʻi i hoʻopilikia ʻia e ka maʻi

ʻO kahi noiʻi Kanada i paʻi ʻia ma Dekemaba 2020 e nānā ana i nā ʻano lapaʻau a me ka paʻakikī o Covid-19 e hōʻike ana. ʻO nā kamaliʻi i loaʻa i ka maʻi ke hana maikaʻi nei. ʻOiaʻiʻo, ʻo ka hapa nui o nā pēpē i hoʻopaʻa ʻia me ke kuni, kahi maʻi maʻalahi a ʻaʻole koi i ka ea uila a i ʻole ka mālama mālama kino.

ʻO Covid-19 kahi maʻi ʻokoʻa loanā mākua, nā keiki… a me nā kamaliʻi. ʻO kahi haʻawina i mālama ʻia e nā mea noiʻi ma ke Kulanui o Montreal a paʻi ʻia ma ka Ka Honua JAMA Open hōʻike i ka mea hope, i hoʻohālikelike ʻia me nā pākeke, hana maikaʻi loa i ka wā i loaʻa ai ka maʻi me SARS-CoV-2. ʻOiai ʻoi aku ka nui o ka pilikia o nā pēpē i ka maʻi nui a me nā pilikia mai nā maʻi maʻamau ʻē aʻe (influenza, respiratory syncytial virus), pehea ke ahulau o kēia manawa?

ʻO ke aʻo ʻana, i mālama ʻia ma CHU Sainte-Justine i nā pēpē (ma lalo o 1 mau makahiki) i hoʻopaʻa ʻia iā Covid-19 i ka wā o ka nalu mua o ka maʻi maʻi ma waena o ka waena o Pepeluali a me ka hopena o Mei 2020, e hōʻike ana he nui ka poʻe i hoʻōla koke a he mau hōʻailona maʻalahi wale nō.Hōʻike ka haʻawina ma Quebec a ma waena o Kanada, ua ʻoi aku ka nui o nā pēpē i ka haukapila ma muli o Covid-19 ma mua o nā pūʻulu makahiki pediatric. Hōʻike nā mea noiʻi mai 1 mau pēpē i hoʻāʻo ʻia, 165 o lākou (25%) ua hōʻike maikaʻi ʻia no Covid-19 a ma waena o kēia mau mea i emi iki mai ka hapakolu (8 mau keiki pēpē) i hoʻopaʻa ʻia i ka haukapila, ʻo kēia mau noho ʻana he ʻelua lā ma ka awelika.

ʻOi aku ka nui o ka hale maʻi akā…

Wahi a ka hui ʻepekema, "keia mau halemai pokoleʻike pinepine ʻia ka hana lapaʻau maʻamau e ʻae ʻia nā keiki hou a pau me ke kuni no ka nānā ʻana, e hoʻopaʻa ʻia i ka maʻi a loaʻa i nā lāʻau antibiotic ke kali nei nā hopena. I ka 19% o nā hihia, ʻo nā maʻi ʻē aʻe, e like me nā maʻi maʻi urinary tract, ke kuleana o ke kuni o ke pēpē. ʻO ka mea nui, ma 89% o nā hihia, maʻiʻaʻai coronavirus ʻAʻohe o nā pēpē i makemake i ka oxygen a i ʻole ka ea uila. ʻO nā hōʻailona maʻamau ka hōʻailona ma ka ʻōpū o ka ʻōpū, a ukali ʻia e ke kuni a me nā hōʻike ʻana o ka ʻōpū hanu luna.

Eia kekahi, ʻaʻohe ʻokoʻa koʻikoʻi o ka hanana maʻi ma waena o nā keiki ʻōpio (3 a 12 mau mahina) a me nā ʻōpio (ma lalo o 3 mau mahina) i ʻike ʻia. “ Nā hōʻailona hōʻailona a meke kaumaha o ka maiʻokoʻa nā kamaliʻi i kā mākou moʻolelo mai nā mea i hōʻike ʻia i nā keiki a me nā poʻe ʻelemakule. Hōʻike ʻia kā mākou poʻe maʻi me ka nui o nā hōʻailona o ka ʻōpū, ʻoiai me ka ʻole o ke kuni, a me ka maʻi maʻamau. », Hoʻohui lākou. ʻOiai ua kaupalena ʻia ke aʻo ʻana e kona liʻiliʻi liʻiliʻi liʻiliʻi, manaʻo ka poʻe noiʻi e hōʻoiaʻiʻo kā lākou ʻike i nā mākua e pili ana i nā hopena. o ka maʻi coronavirus i nā kamaliʻi.

E mālama ʻia kahi noiʻi hou ma CHU Sainte-Justine e hoʻomaopopo i nā ʻokoʻa o ka pane immunological i SARS-CoV-2.i nā kamaliʻi a me ko lākou mau mākua.Pono kekahi hana hou e hoʻomaopopo maikaʻi i nā mīkini pathophysiological i lalo o ka pane ʻana i ka maʻi maʻi i nā pēpē. No ka mea he nīnau koʻikoʻi: no ke aha i ʻokoʻa ai nā hōʻailona maʻi a me ka paʻakikī o ka maʻi i nā pēpē mai nā mea i hōʻike ʻia i nā keiki a me nā poʻe ʻelemakule? ” He mea nui kēia i ka hoʻoponopono ʻana i ka maʻi maʻi e pili anai ka maʻi me SARS-CoV-2i nā pākeke », Hoʻopau nā mea noiʻi.